Literature DB >> 18049289

10-year research update review: psychiatric problems in children with epilepsy.

Sigita Plioplys1, David W Dunn, Rochelle Caplan.   

Abstract

OBJECTIVE: To critically review literature published from 1996 to 2007 on psychopathology in children with epilepsy (CWE).
METHOD: Using Ovid, we searched Medline and PsychInfo databases for original studies on epidemiology, risk factors, clinical characteristics, treatment, and outcome of psychopathology in CWE, ages 0 to 18 years, using the terms "psychopathology," "emotional and behavioral problems," and "mental health problems." We selectively present the findings of studies that are clinically relevant to mental health professionals.
RESULTS: Psychopathology occurs in 37% to 77% of CWE, and attention, internalizing, and thought problems may be specific to epilepsy. Cognitive and linguistic deficits, as well as family factors, have moderating effects on psychopathology in CWE. The association of epilepsy-related variables, including antiepileptic drugs, with psychopathology is inconsistent in cognitively normal CWE. Children with symptomatic epilepsy and devastating epilepsy syndromes have high rates of global developmental delay, hyperactivity, and autistic symptoms. The treatment of psychopathology in CWE integrates standard psychiatric practices.
CONCLUSIONS: Epilepsy is a neuropsychiatric disorder characterized by seizures, psychopathology, cognitive, and linguistic problems. Improved early identification of CWE at risk for psychopathology, evidence-based psychiatric treatment, and multidisciplinary management strategies would advance clinical practice in this highly complex field of pediatric neuropsychiatry.

Entities:  

Mesh:

Year:  2007        PMID: 18049289     DOI: 10.1097/chi.0b013e31815597fc

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  24 in total

1.  Childhood chronic physical condition, self-reported health, and life satisfaction in adolescence.

Authors:  Heidi Määttä; Tuula Hurtig; Anja Taanila; Meri Honkanen; Hanna Ebeling; Heli Koivumaa-Honkanen
Journal:  Eur J Pediatr       Date:  2013-05-08       Impact factor: 3.183

2.  Depression and anxiety in children with epilepsy and other chronic health conditions: National estimates of prevalence and risk factors.

Authors:  Brian LaGrant; Belinda Oyinkan Marquis; Anne T Berg; Zachary M Grinspan
Journal:  Epilepsy Behav       Date:  2019-12-20       Impact factor: 2.937

3.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

4.  Children with epilepsy and anxiety: Subcortical and cortical differences.

Authors:  Jana E Jones; Daren C Jackson; Karlee L Chambers; Kevin Dabbs; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  Epilepsia       Date:  2015-01-12       Impact factor: 5.864

5.  Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats.

Authors:  Patrick A Forcelli; Ryan Kozlowski; Charles Snyder; Alexei Kondratyev; Karen Gale
Journal:  J Pharmacol Exp Ther       Date:  2011-11-30       Impact factor: 4.030

6.  The effect of temperament and neuropsychological functioning on behavior problems in children with new-onset seizures.

Authors:  Katherine T Baum; Anna W Byars; Ton J deGrauw; David W Dunn; John E Bates; Steven R Howe; C-Y Peter Chiu; Joan K Austin
Journal:  Epilepsy Behav       Date:  2010-02-19       Impact factor: 2.937

Review 7.  Epilepsy and autism: neurodevelopmental perspective.

Authors:  Roberto Tuchman; Michael Cuccaro
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

8.  Electrocorticography and seizure outcomes in children with lesional epilepsy.

Authors:  Jennifer N Gelinas; Andrew W Battison; Sherry Smith; Mary B Connolly; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2010-09-21       Impact factor: 1.475

9.  Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.

Authors:  Joseph Gonzalez-Heydrich; Jane Whitney; Deborah Waber; Peter Forbes; Olivia Hsin; Stephen V Faraone; Alice Dodds; Sneha Rao; Christine Mrakotsky; Carlene Macmillan; David R Demaso; Carl de Moor; Alcy Torres; Blaise Bourgeois; Joseph Biederman
Journal:  Epilepsy Behav       Date:  2010-05-21       Impact factor: 2.937

Review 10.  Psychopathology and psychological adjustment in children and adolescents with epilepsy.

Authors:  Soraya Otero
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.